Evidence gaps in the management of sickle cell disease: A summary of needed research

American Journal of Hematology

Volumn 90, Issue 4, 2015, Pages 273-275

  Savage, William J ^a   Buchanan, George R ^b   Yawn, Barbara P ^c   Afenyi Annan, Araba N ^d   Ballas, Samir K ^e   Goldsmith, Jonathan C ^f   Hassell, Kathryn L ^g   James, Andra H ^h   John Sowah, Joylene ⁱ   Jordan, Lanetta ^j   Lottenberg, Richard ^k   Murad, M Hassan ^l   Ortiz, Eduardo ^m   Tanabe, Paula J ^h   Ware, Russell E ⁿ   Lanzkron, Sophie M ^o  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c OLMSTED MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^l Mayo Clinic College of Medicine   (United States)

^m ATLAS RESEARCH   (United States)

ⁿ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^o JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ACUTE DISEASE; ARTICLE; AVASCULAR NECROSIS; CEREBROVASCULAR ACCIDENT; CHOLECYSTITIS; CHOLELITHIASIS; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; EYE DISEASE; HEALTH CARE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MEDICAL EXPERT; MEDICAL RESEARCH; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIAPISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOPATHY; SICKLE CELL ANEMIA; STROKE PATIENT; SYSTEMATIC REVIEW; ANEMIA, SICKLE CELL; COMPLICATION; EVIDENCE BASED MEDICINE;

ANEMIA, SICKLE CELL; ERYTHROCYTE TRANSFUSION; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYUREA; PRACTICE GUIDELINES AS TOPIC;

EID: 84925350470     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23945     Document Type: Article

References (5)

1. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312:1033-1048.
2. Chobanian AV, Bakris GL, Black HR, et al. and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
3. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med 1995;332:1317-1322.
4. Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). Lancet 2011;377:1663-1672.
5. Brawley OW, Cornelius LJ, Edwards LR, et al. National institutes of health consensus development conference statement: Hydroxyurea treatment for sickle cell disease. Ann Intern Med 2008;148:932-938.